Literature DB >> 24503666

Tip variant focal segmental glomerulosclerosis associated with interferon-β treatment of multiple sclerosis.

Rhys Evans1, Pandora Rudd, Paul Bass, Mark Harber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24503666      PMCID: PMC3918624          DOI: 10.1136/bcr-2013-203077

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.
  3 in total

1.  Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

2.  Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.

Authors:  Ryuichiro Kumasaka; Norio Nakamura; Kenichi Shirato; Takeshi Fujita; Reiichi Murakami; Michiko Shimada; Masayuki Nakamura; Hiroshi Osawa; Hideaki Yamabe; Ken Okumura
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

3.  Nephrotic syndrome in a multiple sclerosis patient receiving long-term interferon beta therapy.

Authors:  Manuel Wallbach; Herman J Gröne; Bernd Kitze; Gerhard A Müller; Michael J Koziolek
Journal:  Am J Kidney Dis       Date:  2013-02-01       Impact factor: 8.860

  3 in total
  2 in total

Review 1.  Re-Examining Neutrophil Participation in GN.

Authors:  Dawn J Caster; David W Powell; Irina Miralda; Richard A Ward; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2017-06-15       Impact factor: 10.121

2.  Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review.

Authors:  Maxime Dauvergne; David Buob; Cédric Rafat; Marie-Flore Hennino; Mathilde Lemoine; Vincent Audard; Dominique Chauveau; David Ribes; Emilie Cornec-Le Gall; Eric Daugas; Evangéline Pillebout; Vincent Vuiblet; Jean-Jacques Boffa
Journal:  Clin Kidney J       Date:  2021-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.